Alimera Sciences Stock
Alimera Sciences Stock
Our community is currently high on Alimera Sciences with 4 Buy predictions and 0 Sell predictions.
With a target price of 5 € there is a positive potential of 21.43% for Alimera Sciences compared to the current price of 4.12 €.
Pros and Cons of Alimera Sciences in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alimera Sciences vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Alimera Sciences | - | - | - | - | - | - | - |
Rockwell Medical Inc. | -2.030% | -3.331% | 12.871% | -53.739% | -7.958% | -80.406% | -96.382% |
Avid Bioservices Inc | - | -9.877% | 1.389% | -50.676% | 19.672% | -58.989% | 113.170% |
Gritstone Oncology Inc | -1.050% | -7.230% | -14.614% | -64.133% | -63.052% | -91.159% | - |
Comments
Alimera Sciences, Inc. (NASDAQ: ALIM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Show more
Ratings data for ALIM provided by MarketBeat
Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for ALIM provided by MarketBeat
Alimera Sciences, Inc. (NASDAQ: ALIM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Show more
Ratings data for ALIM provided by MarketBeat